Literature DB >> 22664867

Impact of stent platform of paclitaxel-eluting stents: assessment of neointimal distribution on optical coherence tomography.

Hiromasa Otake1, Junya Shite, Toshiro Shinke, Naoki Miyoshi, Amane Kozuki, Hiroyuki Kawamori, Masayuki Nakagawa, Ryoji Nagoshi, Hirotoshi Hariki, Takumi Inoue, Tsuyoshi Osue, Yu Taniguchi, Noritoshi Hiranuma, Ryo Nishio, Hiroto Kinutani, Ken-ichi Hirata.   

Abstract

BACKGROUND: The Taxus Express™ paclitaxel-eluting stent (Express-PES) and Taxus Liberté™ PES (Liberté-PES) have identical drugs, drug doses, and polymers, but different stent platforms. The Liberté-PES platform has thinner struts, specifically designed for more uniform drug elution. METHODS AND
RESULTS: Fifty-four patients who underwent 6-month follow-up optical coherence tomography (OCT) after Express-PES (n=27) or Liberté-PES (n=27) implantation were enrolled. Longitudinal and circumferential uniformity of neointimal distribution was evaluated in 3-D by computing mean neointimal thickness (NIT) within 360 equally spaced radial sectors for every 1-mm cross-section. After stenting, intravascular ultrasound showed that Liberté-PES had a significantly smaller maximum angle between adjacent struts, with a tendency toward a lower incidence of % length of the segment with maximum angle >90° than Express-PES. Liberté-PES had a significantly thinner mean NIT than the Express-PES with comparable frequency of uncovered struts. Longitudinal and circumferential absolute variation of NIT expressed by standard deviation of NIT from each sector was significantly smaller for Liberté-PES than for Express-PES. Liberté-PES had a tendency toward a decreased incidence of thrombus and peri-strut low-intensity areas (findings suggestive of delayed arterial healing), compared to Express-PES.
CONCLUSIONS: Stent design and thickness appeared to affect neointima suppression of PES. The stent platform of the Liberté-PES may offer greater and more homogeneous reduction of neointimal proliferation spatially across the full length of the PES.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22664867     DOI: 10.1253/circj.cj-11-1363

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  2 in total

1.  Lower on-treatment platelet reactivity during everolimus-eluting stent implantation contributes to the resolution of post-procedural intra-stent thrombus: serial OCT observation in the PRASFIT-Elective study.

Authors:  Akihide Konishi; Masamichi Iwasaki; Toshiro Shinke; Hiromasa Otake; Masayuki Nakagawa; Hirotoshi Hariki; Tsuyoshi Osue; Takumi Inoue; Yu Taniguchi; Ryo Nishio; Hiroto Kinutani; Noritoshi Hiranuma; Masaru Kuroda; Ken-Ichi Hirata; Shigeru Saito; Masato Nakamura; Junya Shite; Takashi Akasaka
Journal:  Heart Vessels       Date:  2018-07-02       Impact factor: 2.037

2.  Effects of daily glucose fluctuations on the healing response to everolimus-eluting stent implantation as assessed using continuous glucose monitoring and optical coherence tomography.

Authors:  Masaru Kuroda; Toshiro Shinke; Hiromasa Otake; Daisuke Sugiyama; Tomofumi Takaya; Hachidai Takahashi; Daisuke Terashita; Kenzo Uzu; Natsuko Tahara; Daiji Kashiwagi; Koji Kuroda; Yuto Shinkura; Yoshinori Nagasawa; Kazuhiko Sakaguchi; Yushi Hirota; Wataru Ogawa; Ken-Ichi Hirata
Journal:  Cardiovasc Diabetol       Date:  2016-05-21       Impact factor: 9.951

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.